Annual Working Capital
$544.24 M
+$209.94 M+62.80%
December 31, 2024
Summary
- As of February 26, 2025, PTGX annual working capital is $544.24 million, with the most recent change of +$209.94 million (+62.80%) on December 31, 2024.
- During the last 3 years, PTGX annual working capital has risen by +$247.52 million (+83.42%).
- PTGX annual working capital is now at all-time high.
Performance
PTGX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$544.24 M
+$112.05 M+25.93%
December 31, 2024
Summary
- As of February 26, 2025, PTGX quarterly working capital is $544.24 million, with the most recent change of +$112.05 million (+25.93%) on December 31, 2024.
- Over the past year, PTGX quarterly working capital has increased by +$112.05 million (+25.93%).
- PTGX quarterly working capital is now -7.39% below its all-time high of $587.64 million, reached on March 31, 2024.
Performance
PTGX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PTGX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.8% | +25.9% |
| 3 y3 years | +83.4% | +25.9% |
| 5 y5 years | +395.2% | +25.9% |
PTGX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +156.8% | -7.4% | +156.8% |
| 5 y | 5-year | at high | +395.2% | -7.4% | +507.3% |
| alltime | all time | at high | +6255.8% | -7.4% | +4811.9% |
Protagonist Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $544.24 M(+62.8%) | $544.24 M(+25.9%) |
| Sep 2024 | - | $432.19 M(-18.4%) |
| Jun 2024 | - | $529.35 M(-9.9%) |
| Mar 2024 | - | $587.64 M(+75.8%) |
| Dec 2023 | $334.30 M(+57.8%) | $334.30 M(+12.6%) |
| Sep 2023 | - | $297.01 M(+2.2%) |
| Jun 2023 | - | $290.54 M(+36.7%) |
| Mar 2023 | - | $212.51 M(+0.3%) |
| Dec 2022 | $211.90 M(-28.6%) | $211.90 M(-11.7%) |
| Sep 2022 | - | $239.86 M(-9.2%) |
| Jun 2022 | - | $264.21 M(-11.4%) |
| Mar 2022 | - | $298.07 M(+0.5%) |
| Dec 2021 | $296.72 M(+7.8%) | $296.72 M(+2.8%) |
| Sep 2021 | - | $288.53 M(-12.3%) |
| Jun 2021 | - | $328.85 M(+31.0%) |
| Mar 2021 | - | $250.99 M(-8.9%) |
| Dec 2020 | $275.37 M | $275.37 M(+66.3%) |
| Sep 2020 | - | $165.59 M(-9.1%) |
| Jun 2020 | - | $182.11 M(+103.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $89.61 M(-18.5%) |
| Dec 2019 | $109.91 M(-1.3%) | $109.91 M(-3.0%) |
| Sep 2019 | - | $113.25 M(+8.9%) |
| Jun 2019 | - | $104.00 M(+5.6%) |
| Mar 2019 | - | $98.50 M(-11.5%) |
| Dec 2018 | $111.34 M(+2.7%) | $111.34 M(-9.8%) |
| Sep 2018 | - | $123.40 M(+15.2%) |
| Jun 2018 | - | $107.09 M(-1.1%) |
| Mar 2018 | - | $108.31 M(-0.1%) |
| Dec 2017 | $108.39 M(+41.1%) | $108.39 M(+138.4%) |
| Sep 2017 | - | $45.46 M(-23.9%) |
| Jun 2017 | - | $59.76 M(-0.0%) |
| Mar 2017 | - | $59.77 M(-22.2%) |
| Dec 2016 | $76.81 M(+593.2%) | $76.81 M(-20.7%) |
| Sep 2016 | - | $96.90 M(+429.3%) |
| Jun 2016 | - | $18.31 M(-30.8%) |
| Mar 2016 | - | $26.47 M(+138.9%) |
| Dec 2015 | $11.08 M(+29.4%) | $11.08 M |
| Dec 2014 | $8.56 M | - |
FAQ
- What is Protagonist Therapeutics annual working capital?
- What is the all time high annual working capital for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual working capital year-on-year change?
- What is Protagonist Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly working capital year-on-year change?
What is Protagonist Therapeutics annual working capital?
The current annual working capital of PTGX is $544.24 M
What is the all time high annual working capital for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual working capital is $544.24 M
What is Protagonist Therapeutics annual working capital year-on-year change?
Over the past year, PTGX annual working capital has changed by +$209.94 M (+62.80%)
What is Protagonist Therapeutics quarterly working capital?
The current quarterly working capital of PTGX is $544.24 M
What is the all time high quarterly working capital for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly working capital is $587.64 M
What is Protagonist Therapeutics quarterly working capital year-on-year change?
Over the past year, PTGX quarterly working capital has changed by +$112.05 M (+25.93%)